DERIVATIVES OF 5-ACYLAMINO-1,2,4-THIADIAZOLES, METHOD OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION SHOWING AFFINITY TO CHOLECYSTOKININ RECEPTORS
FIELD: organic chemistry, pharmacy. SUBSTANCE: invention describes new derivatives of 5-acylamino-1,2,4-thiadiazoles of the formula (I) where Ar means an aromatic nitrogen-containing heterocycle taken among quinolinyl, isoquinolinyl, indolyl being the latter can be substituted with a group W at nitr...
Gespeichert in:
Hauptverfasser: | , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | FIELD: organic chemistry, pharmacy. SUBSTANCE: invention describes new derivatives of 5-acylamino-1,2,4-thiadiazoles of the formula (I) where Ar means an aromatic nitrogen-containing heterocycle taken among quinolinyl, isoquinolinyl, indolyl being the latter can be substituted with a group W at nitrogen atom where W is taken from a group involving: (a) -(CH2)nCOR where "n" means 1 or 2 and R means OR1 where R1 is taken from hydrogen atom and (C1-C4)-alkyl; (b) tetrahydropyranyl and (c) chain -(CH2)3 where the last carbon atom is fixed in phenyl ring of indole that results to formation of 6-membered heterocycle; Z means: (a) group where A and B mean -C and X1,X2,X3,X4 are similar or distinct and mean hydrogen atom, chlorine or bromine atom, (C1-C3)-alkyl group, (C1-C3)-alkoxyl group or trifluoromethyl group; (b) naphthyl group and their pharmaceutically acceptable salts also. Compounds show affinity to biological receptors of cholecystokinin. Invention describes also a method of synthesis of derivatives of 5-acylamino-1,2,4-thiadiazoles of the formula (I) by any of p. p. 1-6 that involves an interaction of derivative of 5-aminothiadiazole of the formula (II) where Z has a value indicated in p. 1 with a reactive derivative of an acid of the formula -COOH where has values indicated in p. 1 for Ar or means a derivative of Ar where reactive centers under acylation conditions are protected. Then if necessary protective groups are removed from the above indicated reactive centers of aromatic ring. EFFECT: improved method of synthesis, affinity of synthesized compounds to cholecystokinin receptors. 8 cl, 2 tbl, 9 ex |
---|